ArticleRMD open2026

Mesenchymal stromal cells ameliorate systemic sclerosis-interstitial lung disease via PD-1/PD-L1 signalling axis.

Yuxuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.